Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost Punctal Plug Delivery System in OH or OAG
NCT01229982Phase 2Completed
- Sponsor
- Mati Therapeutics
- Start
- Oct 2010
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in ocular hypertension, open-angle glaucoma (OAG), sponsored by Mati Therapeutics. Started Oct 2010; status: completed.
02
Drugs
latanoprost
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT01229982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229982.